Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
5-25-2018 9:30 AM

Glycopolymer Functionalization of Polymersomes
Josh Jadischke, The University of Western Ontario
Supervisor: Gillies, Elizabeth R., The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Science degree in
Chemistry
© Josh Jadischke 2018

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Materials Chemistry Commons, Organic Chemistry Commons, and the Polymer Chemistry
Commons

Recommended Citation
Jadischke, Josh, "Glycopolymer Functionalization of Polymersomes" (2018). Electronic Thesis and
Dissertation Repository. 5421.
https://ir.lib.uwo.ca/etd/5421

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract
Carbohydrates are important to cellular communication, recognition, and pathogenesis,
making them a useful synthetic target for application in therapeutics and diagnosis. Synthetic
carbohydrate presenting scaffolds can replicate or interrupt the binding interactions that
occur in nature. Due to the weak nature of the monosaccharide-protein bond, most
carbohydrate presenting scaffolds display saccharides in a multivalent manner to improve
binding. Recently there has been an effort to combine carbohydrate containing scaffolds with
polymersomes (vesicles composed of polymers), due to the structural resemblance of
polymersome membranes to biological membranes. This thesis describes the progress
towards functionalizing polymersomes with linear glycopolymers as a potential method to
achieve improved multivalent binding. A novel b-D-Galactose containing polymer was
synthesized using reversible addition-fragmentation chain transfer polymerization. This
polymer, as well as a previously reported glycopolymer based on a polyacrylamide backbone
were labeled with rhodamine in order to quantify their subsequent conjugation to the
polymersome surface. Two different vesicle platforms were investigated, polybutadiene-bpoly(ethylene glycol) and poly(ethylene glycol)-b-poly(ethyl glyoxylate)-b-poly(ethylene
glycol). The experiments suggested that it is possible to conjugate the glycopolymers to the
polymersome surfaces to obtain different glycopolymer densities and quantify the reaction
yields using fluorescence spectroscopy. Future work will involve binding studies of the
glycopolymer-coated vesicles to carbohydrate binding proteins (lectins).

Keywords
Carbohydrates, glycopolymers, carbohydrate scaffolds, polymersomes, vesicles, surface
functionalization, RAFT, multivalency.
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Chapter 1

1

Carbohydrates and their Role in Therapeutics

1.1 Introduction to Carbohydrates

1.1.1

Carbohydrates and their role in Nature

Carbohydrates or saccharides play a crucial role in cellular adhesion and molecular
signaling that occurs at the surfaces of many mammalian and microbial cells.1,2 The
interactions between cells and the surrounding extracellular matrix (ECM) are regulated
by cellular adhesion events that fall under one of three interaction types: protein-protein,
protein–carbohydrate, and carbohydrate–carbohydrate interactions. These interactions
control the binding of connective proteins that form the ECM.3 Carbohydrates displayed
on the surfaces of cells act as identifying molecules that inform cells of their respective
type, thereby allowing for cellular organization and the formation of homogeneousmulticellular tissue.4,5 Signaling molecules regulate the immune response, cancer
metastasis, and act as indicators for disease states in the human body.5

1.1.2

Carbohydrates and the Human Immune System

The innate and adaptive immune systems mimic key interactions between displayed
carbohydrates and complimentary binding proteins on the surface of mammalian cells
and pathogens in order to fight infection. The innate immune system is the part of the
immune system that can protect the body from a wide variety of pathogens. It is partially
composed of different types of phagocytes that can consume and destroy pathogens. For
example, macrophages can identify and trap a virion by multiple carbohydrate-based
mechanisms.5 Mannose Binding Proteins (MBPs) found in the blood stream can bind to
mannose residues displayed on the surface of a virion to form a complex.6 MBP-virion
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complexes can then associate with receptors on the surface of the macrophage to trigger
phagocytosis (Figure 1.1).5,7 Phagocytosis can also be triggered by the binding of sialic
acid residues displayed on a macrophage’s surface sialic acid binding proteins (SABP) or
long linear pendent protein chains to virion surface proteins8; sialic acid functionalized
protein chains act like a net in the blood stream, attempting to capture pathogens that do
not make direct contact with the macrophage’s surface.5

Virus

3) Viral Binding Induced Phagocytosis
+
Immune Response

1) Viral Infection
MBP

Bound Virus

Pendent SABP

2) Binding to Macrophage
Bound
MBP–receptor
SABP

MBP–receptor

Macrophage

Stimulated
Macrophage

Figure 1.1. Binding of viruses to a macrophage presenting MBP-Receptors and SABP’s
to induce phagocytosis and an immune response.
Although the innate immune system provides defense against many invading pathogens,
the adaptive immune system allows for a long term and larger immune response than the
innate system. Dendritic cells, a type of phagocyte from the innate immune system,
display fragments of glycoproteins or glycolipid complexes that were derived from a
previously consumed virion. Specialized lymphocytes interact with the presented
fragments and use the information to trigger an immune response. A dissimilar immune
response targeting the human body’s own cells can be triggered by abnormal or
pathogenic carbohydrate displays on the surface of human cells.
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1.1.3

Carbohydrates and Cancer

The body can identify cancerous cells by the aberrant presentation of carbohydrates on
the surface of the cell.9 Malignant cancer cells often have different carbohydrates
presented due to the fact that they have different cellular adhesion and mobility than
typical cells.10 Increased glycosylation of surface glycoproteins has been observed in
multiple types of cancer including breast, prostate, and pancreatic cancers.10 Higher
degrees of glycosylation have been speculated to increase the ability of tumors to
metastasize by improving binding of the cancerous cells to the walls of blood vessels.10
Unique and cancer specific antigens are displayed by cancerous cells.11 Thus, these
antigens have been considered to be a useful target for potential cancer vaccines or
targeted drug delivery. Carbohydrates have widely been hailed as potential therapeutics
but to understand the design of such therapeutics, a closer look at the nature of
carbohydrate bonds is required.

1.2 The Nature of Carbohydrate Binding

1.2.1

Carbohydrate–Protein Binding

Carbohydrates typically bind to proteins and other carbohydrates through weak
intermolecular forces. When binding to proteins, carbohydrates typically bind either in
pockets or grooves on the surface of a protein. Pockets only allow specific saccharides
with a certain conformation to favourably bind (Figure 1.2); grooves offer a less specific
binding. Non–covalent hydrogen bonding of saccharide hydroxyl groups to aspartic acid,
asparagine, glutamic acid, glutamine, and arginine residues are the most important and
strongest binding interactions.12,13 The formation of new hydrogen bonds is important to
the spontaneous binding of saccharide to proteins. However, to understand the binding of
mono-, oligo- or polysaccharides to proteins, driving forces other than hydrogen bond
formation must also be introduced.13
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Figure 1.2. Schematic illustrating the effect of binding of galactose to a binding pocket.

b-galactose favourably binds to the protein where α-galactose does not bind favourably
due to steric hindrance.12

The spontaneous binding of carbohydrate presenting molecules to complimentary lectins
is assumed to be a model system for carbohydrate-protein binding interactions. “Lectins
are proteins of nonimmune origin that bind to specific carbohydrates without modifying
them,” and have been found in most microorganisms and multi-cellular organisms.5,13 In
a binding interaction, initially both the carbohydrate and site of binding are solvated,
typically with water molecules. The water molecules at the site of binding are suspected
to be highly ordered and in a higher-energy state than water molecules interacting in
bulk.13 When the carbohydrate hydroxyl groups interact with amino acid residues at the
site of binding, the high-energy water molecules are displaced, and become lower in
energy.13,14 The breaking of the hydrogen bonds contributes a small negative ∆H term to
∆G, in ∆G = ∆H -T∆S, where a negative ∆G indicates spontaneous binding. There is an
enthalpic cost associated with the formation of new water–water hydrogen bonds, but it is
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compensated for by the slightly larger entropic contribution of solvent rearrangement to
∆S.15 The rearrangement of highly–ordered water molecules surrounding the hydrophobic
portions of the carbohydrate and lectin binding site to disordered water molecules is
highly favours entropy. Thus, solvent rearrangement is the main driving force behind
carbohydrate–lectin binding.13,15 The binding site favours the binding of a specific
conformation of the carbohydrate, but conformational binding and locking reduces the
rotational freedom of the carbohydrate bonds. This reduction in rotational freedom is
associated with a small entropic cost that makes ∆G slightly less negative.
Monosaccharide-lectin binding is determined by the above enthalpic and entropic
interactions.4 Oligosaccharides and molecules that present multiple copies of a saccharide
have a more favourable binding to lectins due to the multivalent effect.

1.2.2

Multivalent Carbohydrate Binding to Lectins

The increased binding of oligosaccharides, glycopolymers, glycoproteins, and glycolipids
in biological systems may offer an explanation for why many key binding interactions
rely on molecules displaying multiple carbohydrates. One reason multivalent
carbohydrate binding moieties may have stronger interactions with lectins, is that lectins
and some other proteins contain multiple binding sites.13 For example, in the binding of
glycopolymers, an entropic cost is initially paid when one of the saccharides adapts the
required binding conformation; flexible and freely rotating glycopolymers have more
entropy than bound glycopolymers.13 Other saccharides on the glycopolymer are now
free to bind to another site on the lectin without paying the same initial entropic cost,
increasing the favourability of the second saccharide binding event. Upon binding of a
multivalent carbohydrate there may also be a large local concentration of saccharides,
contributing to the multivalent effect. After a single saccharide binds to the
complementary lectin, many saccharides populate the local environment, shifting the
equilibrium to favour binding. It can be imagined that either interactions with another
binding site, or interaction with the same binding site, after disassociation, would be
possible.5,13 The multivalent effect on binding is expected to be driven by a combination
of entropic and concentration–based effects.4 Due to the increased binding and
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prevalence of polyvalent carbohydrates in nature, many therapeutic scaffolds taking
advantage of the multivalent effect have been proposed over the years.

1.3 Carbohydrate Presenting Scaffolds for use in
Therapeutics

1.3.1

Naturally Occurring Glycopolymers

Scaffolds presenting polyvalent carbohydrates are often designed to replicate
carbohydrate presentation in nature. A natural glycopolymer that has been shown to have
many therapeutic applications is hyaluronan, a derivative of hyaluronic acid (Figure 1.3).
Hyaluronan is a glycopolymer found in many living organisms and in the ECM of
cartilage in humans.16 It has applications in ophthalmology, treatment of osteoarthritis,
and wound healing, where the hyaluronan often acts as a lubricant or moisturizer.17
Hyaluronan can be modified through semi-synthetic methods to alter the properties.
However, synthetic glycopolymers offer distinct advantages over natural or semisynthetic glycopolymers.

Figure 1.3. Structure of Hyaluronic Acid, a natural glycopolymer.
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1.3.2

Synthetic Glycopolymers

Synthetic glycopolymer scaffolds have been developed to control structural properties
including molar mass and the presented saccharide. A high degree of variability in molar
mass (number of presented saccharides) within a particular glycopolymer sample, or a
polydisperse sample, increases the variability of action for biological applications. In
contrast, monodisperse samples, or samples with a low degree of variability in molar
mass, have reproducible properties and less therapeutic variability.5,18 Glycopolymers
with a molar mass under 100,000 g/mol have been shown to avoid stimulating parts of
the immune system, creating greater specificity of action.10 The carbohydrate presented
often determines the application of a glycopolymer. For example, the Influenza A virus is
coated in proteins that specifically bind to sialic acid.5,19,20 A natural glycopolymer
containing sialic acid residues, mucin, can neutralize a virus as seen in Figure 1.4 (a).
Tsuchida and co-workers took advantage of this and designed a synthetic glycopolymer
with sialic acid residues to neutralize the infectious capability of viral particles as shown
in Figure 1.4.20 Short synthetic glycoproteins, or glycosylated polypeptide sequences,
have been shown to have similar neutralization potential to viral particles.21

Figure 1.4. (a) Neutralization of an influenza virus with mucin, a natural glycoprotein
containing sialic acid groups. The mucin inhibits binding of the virus to the cell,
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preventing invasion. Modified and reprinted with permission.19 (b) Structure of sialic acid
glycopolymer derivative used to neutralize Influenza A.

1.3.3

Glycopeptides

Glycopeptides are synthetic glycopolymers based on peptide linkages between
glycosylated amino acid derivatives. Peptide synthesis involves sequential deprotection
and protection steps leading to discrete peptide sequences which improves the
reproducibility of experimental results.22 Control over the peptide sequencing allows for
the fine tuning of distances between binding groups and can change the presented
carbohydrate patterns.23 For example cyclic glycopeptides present carbohydrates in a
unique manner (Figure 1.5).21 Synthetic glycoproteins, as a class of scaffolds, are
generally highly biocompatible due to the fact that most organisms possess the enzymes
to break down peptide linkages.

Figure 1.5. (a) Sialylated lactose cyclic glycopeptide shown to neutralize Influenza A.21
(b) Pentasaccharide core of N-glycans.24
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1.3.4

Glycoconjugates

Glycoconjugates are another biocompatible scaffold that use glycosylated proteins,
antibodies, or antigens as therapeutics. The term glycoconjugate refers to any protein or
antibody that has a glycopolymer, oligosaccharide, or glycopeptide covalently bound, or
conjugated, to its surface to improve its targeted delivery.5 N-glycans are an example of
naturally occurring glycoconjugates. N-Glycans have the same pentasaccharide core as
shown in figure 1.5 with functionalization of the hydroxyls observed.24 Although
glycoconjugates show potential for a wide variety of applications, available synthetic
transformations are limited to reaction conditions that will not destroy the biological
activity of the protein.24,25 Glycosylation reactions often require anhydrous conditions
which are incompatible with many proteins.23 The present synthesis of glycoconjugates,
like N-glycans, relies on enzymatic transformations which have issues of site-specific
reactivity.24,25 Despite difficulties with synthesis, glycoconjugate therapeutics have been
developed. For example, branched glycoproteins conjugated to a protease that could
cleave a specific receptor on a bacterial pathogen. The glycoconjugate of the protease
showed an improvement in efficacy by 103 over the protease.5

1.3.5

Glycodendrimers

Glycodendrimers are a class of branched glycopolymers that are both well-defined and
present carbohydrates in a multivalent manner.26 The molecule typically branches away
from a central point with selected reactive or functional groups at the outer terminus.26
Dendrimers are often synthesized generationally using a series of protection, coupling,
and deprotection steps similar to polypeptides.7,27 Each growth step increases the
generation and branching of dendrimers, where G0 is the initial generation and the third
generation, G3, has had at least three growth steps increasing the branching. These
discrete generational synthetic steps lead to high degrees of control over the size and
consequently the size dependent properties. The effect of dendrimer generation and
number of presented saccharide units was observed in a study by André et al. where they
tested lactose functionalized glycodendrimers as an inhibitor of (AB)2-toxic agglutinin, a
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toxic lectin found in mistletoe.28 Glycodendrimers of generation G3-G5, displayed 32
(Figure 1.6) to 128 lactose molecules, which showed a 10 to 100 fold increase in relative
inhibition potency over lower generation dendrimers, G0-G2, which displayed 4 to 16
lactose molecules.28 A high-density of terminal functional groups increases binding
affinity for certain systems. 18

Figure 1.6. Structure of the lactose–functionalized starburst glycodendrimer synthesized
by André et al.28
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1.3.6

Carbohydrate Functionalized Nanoparticles

Functionalized nanoparticles composed of gold, iron oxide, and other semi-conductive
metal nuclei have been functionalized with carbohydrates creating the field of
glyconanoparticles.29 The metallic nucleus of a glyconanoparticle gives the particle
inherent magnetic and electrochemical properties, and the use of a radionuclide makes a
glyconanoparticle

a

multimodal

imaging

scaffold.29 Goldnanoparticles

(GNP)

functionalized with lactose, Figure 1.7, showed strong binding to galectin-1, a
mammalian b-galactoside-specific lectin.30 An overcrowding effect was observed with
the lacto-GNP, where a decreased binding to the lectin was associated with 100 percent
surface functionalization.30 Similar lacto-GNP were applied in anti-adhesion therapy in
mice.31,32 The metastasis of a melanoma cell line in mice treated with lacto-GNP was
inhibited up to 70% in comparison to untreated mice.32 Cationic glycopolymer
functionalized GNPs have shown potential as gene delivery vehicles. The particles had a
transfection efficiency of approximately 55 %.33
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Figure 1.7. Simplified representation of a lactose–functionalized goldnanoparticle.30

1.4 Carbohydrate Presenting Assemblies and their
Applications

1.4.1

Micelles

Nano-assemblies composed of amphiphilic molecules have been of interest to scientists
for many years due to their abilities to encapsulate a variety of hydrophilic and
hydrophobic cargo and their ability to mimic cell membranes.34 Amphiphilic molecules
can spontaneously self-assemble to form unique morphologies, usually determined by the
hydrophilic weight fraction of the molecule.34 Micellar morphologies have been observed
from the self-assembly of amphiphilic glycopolymers. For example, Suriano et al.
synthesized a galactose–functionalized polycarbonate block copolymer using ring
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opening polymerization (Figure 1.8 (a)). From the block copolymer they were able to
form micelles that could be loaded with doxorubicin, an anti-cancer drug. The galactosefunctionalized micelles showed specific uptake into liver carcinoma cells (HepG2) over
glucose functionalized analogues. The results therefore indicated the potential for
targeted delivery of anti-cancer drugs using glyco-assemblies.35 The micellar morphology
allows for the loading of hydrophobic cargo, however hydrophilic cargo may be loaded
into a variety of other assembly morphologies.

Figure 1.8. (a) Self–assembly of galactose-functionalized amphiphilic polycarbonatebased polymer into a micelle loaded with hydrophobic cargo.35 (b) Self–assembly of
PGalSMA amphiphilic block copolymer or a twin-twin amphiphilic glycodendrimer into
a vesicle loaded with hydrophobic and hydrophilic cargo.36,37

1.4.2

Polymersomes

A vesicle morphology is observed when a bi-layer is formed during the self-assembly of
amphiphilic molecules. Vesicles have been observed to result from the self-assembly of
lipids, dendrimers, and block copolymers.38,39 Polymethacrylate block copolymers
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conjugated with galactose (PGalSMA) have been synthesized using reversible addition–
fragmentation chain–transfer (RAFT) polymerization. RAFT is a method of controlled
polymerization that can afford monodisperse polymer samples, or samples that contain
polymer chains all of similar molecular weight.40 Monodisperse polymer samples are
important for self–assembly due to the sensitive nature of the hydrophilic–hydrophobic
ratio that determines assembly morphology. It is common for amphiphilic block
copolymers used in therapeutic scaffolds, PGalSMA for example, to be synthesized using
RAFT polymerization to improve reproducibility and reliability.41 PGalSMA has been
shown to assemble into vesicles (Figure 1.8 (b)).36 A hydrophilic rhodamine-based dye
that cannot normally undergo cellular uptake was loaded into the PGalSMA vesicles.
Staining of internal cellular organelles indicated cellular uptake and successful cargo
delivery. 36

1.4.3

Dendrimersomes

Percec and coworkers have synthesized Janus glycodendrimers using a modular strategy
that allowed the authors to produce vast libraries of glycodendrimers.38 The libraries
enabled them to determine the effects of crystallinity, saccharide, and linker lengths on
assembly morphology.37 Glycodendrimers with a variety of saccharides were able to form
giant glycodendrimersomes, which are assemblies of micrometer-scale. Due to their size,
bi-layer membrane, and multivalent presentation of surface carbohydrates, the
glycodendrimersomes were presented as a new potential cellular mimic.38 Gillies and coworkers synthesized a-galactose-presenting glycodendrimers which could self–assemble
into vesicles. These a-galactose glycodendrimersomes were able to stimulate invariant
natural killer T (iNKT) cells.27 iNKT cells are normally stimulated by a-galactose
presented in a multivalent manner, which is associated with pathogenesis.27 Selfassemblies displaying carbohydrates in a multivalent manner provide a unique
opportunity to act as delivery agents and biological mimics for use in therapeutics and the
study of biological activity.
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1.5 Thesis Objectives

1.5.1

Project Background

In previous work by the Gillies group, polymersomes were functionalized with
dendrimers

using

a

copper–catalyzed

azide–alkyne

cycloaddition

(CuAAC)

reaction.39,42,43 It was determined that post-assembly modification of polymersomes using
CuAAC did not disrupt the assembly morphology.42 Varying degrees of surface
functionalization were possible by altering the ratio of azide-functionalized to
unfunctionalized amphiphilic polymer used to form the polymersomes.39,42,43 The Gillies
group successfully functionalized polybutadiene-b-poly(ethylene oxide) (PBD-b-PEO)
polymersomes with sialic acid derivatized glycodendrimers.7 These glycodendrimer
functionalized assemblies were shown to bind well to complimentary lectin but the ability
of the assemblies to prevent the binding of influenza A viruses to mammalian cells was
found to be limited. This was believed to result from the rigidity of the glycodendrimer
structures. It can be imagined, that when surrounding a spherical virus with other spheres,
the area of contact would be relatively limited. Because of the previous results, it was
speculated that an improvement in binding could be achieved by introducing flexible
linear glycopolymers to the surfaces of the polymersomes. This would instead allow
octopus-like structures to surround the virus. Given the role of carbohydrates in
numerous biological processes, it was proposed that glycopolymer-functionalized
polymersomes could potentially serve as multivalent inhibitors of viral infection,
vaccines, or targeted drug delivery vehicles that would resemble cell membranes. In
addition, they could simultaneously serve as carriers for hydrophobic and hydrophilic
cargo such as drugs or imaging agents. The surface functionalization density and
glycopolymer chain length may also give important information about the optimal
surface structure for lectin binding.

In unpublished Gillies group work, the successful polymerization of an acrylamide
functionalized ß-galactose monomer using RAFT had been achieved.44 Small quantities
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of alkyne terminated low molecular weight polymer, high molecular weight polymer, and
monomer were previously synthesized and available for test reactions. The alkyne endgroup of the polymer could potentially undergo a CuAAC reaction with azide
functionalized PBD-b-PEG polymersomes (Figure 1.9). PBD-b-PEG was chosen as the
amphiphilic block co-polymer because it has previously been used to produced vesicles
using the film-hydration method.42 Film hydration was selected as a method of selfassembly because it allows for the facile encapsulation of both hydrophobic and
hydrophilic cargo, while generally avoiding bio-incompatible organic solvents.
Preliminary experiments had been performed to investigate the coupling of the linear
polymers onto the vesicles.

Alkyne Terminated
Glycopolymer

CuAAC

Vesicles with Azide
Functional Group

Glycopolymer
Functionalized
Vesicles

Figure 1.9. Schematic showing the method for functionalizing polymersomes with
glycopolymers.

1.5.2

Project Objectives

For this thesis, it was proposed to prepare and study four different functionalized
polymersome systems to examine the effects of both glycopolymer chain length and
density on binding to lectin. Low and high densities of short and long polymers were
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proposed (Figure 1.10). Efficacy of the CuAAC reaction between the polymersomes and
glycopolymers needed to be quantified to make accurate conclusions about the effect of
glycopolymer density on binding.39,42,43 It was proposed that this could be accomplished
using a similar method as shown in Figure 1.9 above, but with dye-labeled
glycopolymers. This thesis describes the progress towards these goals.

Short Glycopolymer – Low Density

Short Glycopolymer – High Density

Long Glycopolymer – Low Density

Long Glycopolymer – High Density

Figure 1.10. Diagram showing the four degrees of glycopolymer functionalization
targeted.
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Chapter 2

2

Results and Discussion

2.1 Synthesis and Characterization of Glycopolymers

In prior work by the Gillies group, polyacrylamides with terminal alkynes and pendant
galactose moieties had been synthesized with two different degrees of polymerization
(DPn) and consequently two different number average molar masses (Mn). A RAFT
polymerization approach had been used to provide glycopolymers with low dispersities
(Đ). 200 mg of PAGal9 (DPn ~9, Mn = 2,400 g/mol, Đ = 1.2, based on size exclusion
chromatography (SEC) in water) and 100 mg of PAGal19 (DPn ~19, Mn = 5,200 g/mol, Đ
= 1.3) were available for test reactions on polymer vesicle surfaces.44 To quantify the
extent of reaction with the vesicle surface, a fluorescent dye was conjugated to each of
PAGal9 and PAGal19 (Scheme 2.1). This was accomplished using a N-(3dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC.HCl) coupling reaction
in the presence of 4-dimethylaminopyridine (DMAP) to react the carboxylic acid group
of rhodamine B with a small number of the hydroxyl groups of the pendant b-galactose
moieties. It was desirable to modify only a small fraction of the sugars to minimize the
structural modification of the polymer and therefore reduce any impact of the dye
molecules on the properties of the conjugated glycopolymers. The product was purified
by dialysis against water using a 1,000 g/mol molecular weight cut-off (MWCO)
membrane.
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Scheme 2.1. Synthetic scheme for the coupling of rhodamine B onto PAGal.

The 1H NMR spectra of the rhodamine functionalized polymers PAGal9-Rho and
PAGal19-Rho had a new broad peak in the aromatic proton region that were
characteristic of the rhodamine dye, indicating the successful coupling of rhodamine onto
the polymer (Figure 2.1). Based on the relative integrations of peaks at ~7.5 ppm and
~4.3 ppm in the 1H NMR spectra, the rhodamine was conjugated in ~7% molar
equivalents for PAGal9-Rho and ~9% molar equivalents for PAGal19-Rho, compared to
the individual repeat units.
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Figure 2.1. 1H NMR spectra of PAGal9-Rho showing the characteristic rhodamine dye
peak (600 MHz, DMSO-d6).

Polymers PAGal9 and PAGal19 were suitable for test quantification reactions but for the
lectin binding tests more of these polymers were required. Consequently, more of
monomer needed to be synthesized and polymerized. To accomplish this, replication of
the synthesis shown in Scheme 2.2 was attempted.44 First, the pentaacetate-protected Dgalactose was synthesized by the reaction of D-galactose refluxing acetic anhydride in the
presence of sodium acetate. The D-galactose pentaacetate was then selectively
glycosylated with azido ethanol using boron trifluoride etherate to afford the b-anomer of
compound 1. A saccharide-based impurity, < 10% by H NMR, suspected to be Dgalactose pentaacetate, was observed in a 1H NMR spectrum of ‘purified’ compound 1.
After multiple attempts to purify compound 1 further using column chromatography, the
synthesis was continued with the hope that purification at a later step would be possible.

21

The azide group in compound 1 was reduced using Lindlar’s catalyst, Pt on CaCO3
poisoned with 5% Pb, suspended in ethanol in a hydrogen gas environment. To avoid a
reaction of the newly formed amine group and the acetyl protecting group, para-toluene
sulphonic acid was used as a temporary protecting group by forming the ammonium salt,
compound 2. In the final step, to afford monomer AAcGal, the ammonium group was
deprotonated with excess N,N-diisopropylethylamine (DIPEA) allowing for the formation
of the amide with the acryloyl chloride.

Scheme 2.2. Synthesis of monomer AAcGal, b-D-galactose pentaacetate functionalized
acrylamide monomer.

A high degree of difficulty with the synthesis and purification at the final step of
synthesizing monomer AAcGal was experienced. The TLC of crude AAcGal showed
multiple products with 3 spots staining with ninhydrin, indicating the presence of an
amine or amide. After collecting what seemed to be the product containing fractions from
column chromatography, the 1H NMR spectrum still indicated the presence of impurities
which were not removed upon re-purification with column chromatography. It should be
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noted that after the first column, the yield dropped from ~14 g of crude product to ~ 4 g.
It had been previously reported in unpublished Gillies group work that this acrylamide
monomer was exceptionally reactive and could auto polymerize. Butylate hydroxytoluene
(BHT), a radical inhibitor, was added to the eluent to prevent auto-polymerization, but
the drastic decrease in yield could still be attributed to auto-polymerization of the
monomer on the column and removal of the impurities present in the crude product. The
vinyl proton shifts in the 1H NMR spectrum under-integrated relative to what was
expected for the product, supporting the hypothesis that auto-polymerization could have
occurred. The final synthetic step for monomer AAcGal was repeated two more times
with freshly distilled acryloyl chloride, DIPEA, and CH2Cl2. It has previously been stated
in the literature that “The synthesis, isolation, and purification of glycomonomers is
notoriously difficult.” 36

Due to the difficulty with replicating the synthesis of monomer AAcGal, synthesis of a
new styrenic monomer, SAcGal, was explored (Scheme 2.3). In the first step, propargyl
alcohol was deprotonated with sodium hydride in anhydrous tetrahydrofuran (THF) and
substituted for the chlorine of 4-vinylbenzyl chloride, 3, to afford compound 4. Crude
compound 1 underwent a CuAAC reaction with pure compound 4 to yield SAcGal.
Based on 1H NMR spectroscopy, SAcGal was pure after purification using a simple silica
plug (Figure 2.2). IR spectroscopy showed no peak at ~2095 cm-1 indicating that there
was no free azide remaining. The first step in the synthesis of SAcGal had a quantitative
yield and the second step had a yield of 55%. SAcGal was stored with BHT to prevent
auto-polymerization. The BHT inhibitor was removed using a silica plug immediately
before polymerization.
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Scheme 2.3. Synthesis of the monomer SAcGal, a b-D-galactose pentaacetate
functionalized styrenic monomer.

Figure 2.2. 1H NMR spectrum of SAcGal (400 MHz, CDCl3).

24

RAFT polymerization was selected because it enabled control over important
glycopolymer properties including the molecular weight, dispersity, and end-groups.
Exemplified by PAGal9 and PAGal19, where the RAFT chain transfer agent (CTA) 5
contained an alkyne group (Scheme 2.4). Due to the nature of RAFT polymerization, the
alkyne functionalized portion of the CTA would be incorporated into one of the
glycopolymer terminal ends. This alkyne end-group could undergo CuAAC with the
azide on the surface of the polymersomes to conjugate the glycopolymer to the
polymersomes.

The

RAFT-mediated

polymerization

was

initiated

with

azobisisobutyronitrile (AIBN), 6, a thermal radical initiator. All free radical
polymerization reactions are highly sensitive to O2 (g), which can react with radicals. To
remove oxygen, two methods were explored: Freeze-pump-thaw and bubbling N2 gas
through the polymerization mixture. Freeze-pump-thaw yielded the most consistent
polymerization results likely due to inconsequential changes in concentration during the
process. When bubbling N2 gas through a polymerization mixture an ice bath is
commonly used to reduce evaporation of the solvent, but a change in concentration and
rate of polymerization was observed. To improve consistency freeze-pump-thaw was
used. After degassing the polymerization mixture, it was heated at 70 ºC to initiate the
polymerization.
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Scheme 2.4. RAFT-mediated polymerization of SAcGal and the subsequent deprotection
and functionalization with Rhodamine B.

Similar to the initial glycopolymers PAAcGal9 and PAAcGal19, two glycopolymers with
different lengths were synthesized (Table 2.1). Mn, DPn, and Đ of the polymers were
determined from SEC in THF relative to polystyrene standards, where calculating DPn
involved dividing the Mn by the molar mass of the repeat unit, 560 g/mol. End-group
analysis by 1H NMR spectroscopy was also used to determine a DPn of the polymers. To
determine DPn the integration value of the CH2 group next to the trithiocarbonate group
(set to 2.0) was compared to the integration value of the saccharide’s anomeric proton
(Figure 2.3). The short protected glycopolymer PSAcGal8 had an Mn of 4,700 g/mol, DPn
of ~8, and Đ of 1.1 based on SEC, and an Mn of 6,700 g/mol and DPn of ~12 based on 1H
NMR. The long protected glycopolymer PSAcGal18 had an Mn of 10,000 g/mol, DP of
~18, and Đ of 1.1 based on SEC, and an Mn of 21,000 and DPn of ~38 based on 1H NMR.
The low dispersities determined by SEC demonstrate that the polymerizations were well
controlled (Figure 2.4). It is unclear whether the Mn values determined by SEC or 1H
NMR are more representative of the true average molar mass for each polymer sample.
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The values determined by SEC are limited by how similar the solvated conformation of
PSAcGal is to the polystyrene calibration standards in THF. The Mn calculated using 1H
NMR spectroscopy is limited by the accuracy of the integration values, which are highly
dependent on the conditions and parameters used to obtain the 1H NMR spectrum and the
subsequent data processing. The important conclusion that can be drawn based on the
relative DPns from SEC and 1H NMR spectroscopy, is that a shorter polymer, PSAcGal8,
and a longer polymer, PSAcGal18, were successfully synthesized. Based on thermal
analysis of PSAcGal8, onset of decomposition temperature, To, was determined to be 315
ºC using thermogravimetric analysis (TGA), and the glass transition temperature was
determined to be 70 ºC using differential scanning calorimetry (DSC).

Table 2.1. Summarized characterization results for short and long protected
glycopolymer PSAcGal. Determined by a SEC, b TGA, c DSC, d 1H NMR spectroscopy.
Polymer

Mn (g/mol) a DPna Đ a

To (ºC) b

Tg (ºC) c

Mn (g/mol) d

DPnd

315

70

6,700

12

21,000

38

Sample
PSAcGal8

4,700

8

1.1

PSAcGal18

10,000

18

1.1
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Figure 2.3. 1H NMR spectrum (400 MHz, CDCl3) of PSAcGal8 with the reference peaks
for end-group analysis labelled.

PSAcGal18

PSAcGal8

Figure 2.4. SEC traces of PSAcGal8 and PSAcGal18 in THF with refractive index
detection.
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The galactose functional groups on PSAcGal8 and PSAcGal18 were then deprotected,
post-polymerization, using sodium methoxide in anhydrous methanol.

1

H NMR

spectroscopy showed the disappearance of the acetyl protecting groups at ~2 ppm, which
indicated successful deprotection of the hydroxy groups, yielding PSGal8 and PSGal18. A
small percentage of the exposed hydroxy groups, on each polymer PSGal8 and PSGal18,
were then functionalized with rhodamine B using the conditions described above for
PAGal9 and PAGal19 (Scheme 2.4). The dye labeled glycopolymers, PSGal8-Rho and
PSGal18-Rho had broad stryenic backbone peaks in aromatic region of the 1H NMR
spectrum, making it difficult to determine the exact number of conjugated rhodamine
molecules.

2.2 Azide Functionalized PBD-PEO Polymersomes

The Gillies group has previously reported the preparation of azide-functionalized
polymersomes from azide-terminated polybutadiene-b-poly(ethylene glycol) (PBD-PEG)
block copolymers.42 As previously reported, coupling of hydroxyl-terminated PBD-PEG
(PBD-PEG-OH) with azidoacetic acid, 7, using N,N’-dicyclohexylcarbodiimide (DCC)
and DMAP allowed for the synthesis of PBD-PEG-N3 (Scheme 2.5). The polymersomes
were assembled using an optimized thin-film hydration method. By varying the ratio of
PBD-PEG-OH and PBD-PEG-N3, the density of azides on the polymersome surface
could be tuned. The PBD-PEG-OH and PBD-PEG-N3 were weighed out in the targeted
ratio and dissolved in CHCl3. The solvent was evaporated under a stream of nitrogen,
then the vial was put under high-vacuum for 16 hours to yield a thin-film. The film was
hydrated with Milli-Q water at 46 °C overnight, then stirred rapidly at 46 °C for 16 hours
to afford polymersomes. The initial compositions tested were 10% and 100% PBD-PEGN3, with the remainder being PBD-PEG-OH. Polymersomes were imaged using confocal
laser scanning microscopy (CLSM) by incorporating nile red, a fluorescent probe, into
the hydrophobic membrane of the polymersome. This was accomplished by the addition
of 0.1 weight percent (wt%) of nile red to the polymer in CHCl3 during the polymer film
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preparation. CLSM images of the PBD-PEG assemblies confirmed the vesicle
morphology (Figure 2.5 (a)). The polymersomes were approximately 3-5 µm in size.
O

7 N3
b
110

O

H
90

OH
O

DCC, DMAP

b

CH2Cl2, r.t., 16 h

PBD-PEG-OH

110

O

N3
90

PBD-PEG-N3

Scheme 2.5. Synthesis of azide functionalized PBD-PEG (PBD-PEG-N3).

a)

b)

Figure 2.5. CLSM images of 100% PBD-PEG-N3 polymersomes: a) loaded with nile red
and (b) with rhodamine functionalized glycopolymer, PAGal19-Rho, conjugated to the
surface.

Next, polymersomes containing 10% and 100% PBD-PEG-N3 were assembled without
nile red. These assemblies were reacted with rhodamine functionalized polymers using
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CuAAC by adding CuSO4, (+)-sodium L-ascorbate, bathophenanthrolinedisulfonic acid
disodium salt hydrate (BPS), and either PAGal9-Rho or PAGal19-Rho to the
polymersome

solution

(Scheme

2.6).

After

the

CuAAC reaction,

unreacted

glycopolymer, CuSO4, (+)-sodium L-ascorbate, and DPS were removed by dialysis
against water using a 50,000 MWCO membrane. A control experiment, where no CuSO4
was added to the reaction mixture, was conducted to confirm that any unreacted dyed
glycopolymer was removed using dialysis. The glycopolymer coated assemblies were
imaged using CLSM. Images indicated that the vesicle morphology was retained postfunctionalization with PAGal9-Rho or PAGal19-Rho at 10% and 100% surface
functionalization densities (Figure 2.5 (b)). PSGal-Rho polymers were conjugated to
PBD-PEG-N3 polymersomes using the same methods above. CLSM images similarly
indicate that vesicle morphology was retained post-functionalized with PSGal8-Rho at
10% and 100% surface functionalization densities (Figure 2.6). PSGal18-Rho
functionalized assemblies were not able to be successfully imaged at either surface
density.
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Scheme 2.6. Preparation of PAGal-Rho-functionalized PBD-PEG polymersomes.

b)

a)

10 µm

10 µm

Figure 2.6. CLSM image of (a) 10% PBD-PEG-N3 and (b) 100% PBD-PEG-N3
polymersomes conjugated with PSGal9-Rho.
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2.3 Quantification of CuAAC with Azide Functionalized
PBD-PEO Polymersomes

PBD-PEG polymersomes functionalized with dye labelled glycopolymers were used to
determine the percent of surface functionalization for PAGal9-Rho, PAGal19-Rho, and
PSGal8-Rho. Fluorescence spectroscopy was used to determine the concentration of
rhodamine labelled glycopolymer present after the reaction and purification of the
polymersomes by dialysis. This was determined by comparing the fluorescence counts of
the decorated polymersomes in dimethyl sulfoxide (DMSO) to the fluorescence counts of
a calibration curve for the corresponding dye labelled polymer PAGal9-Rho, PAGal19Rho, and PSGal8-Rho in DMSO. A calibration curve was created for each PAGal9-Rho,
PAGal19-Rho, and PSGal8-Rho because they had different percentages of dye
functionalization. The results indicated that polymersome samples prepared from 10 wt%
of PBD-PEG-N3 had a higher degree of N3 groups functionalized with dye labelled
glycopolymers PAGal9-Rho and PAGal19-Rho (Table 2.2). The lower degree of N3
groups functionalized on the 100 wt% of PBD-PEG-N3 polymersome samples may be
due to the steric hindrance that is associated with functionalizing every N3 group.
Glycopolymer length appeared to have no significant effect on the percentage of
functionalized azide groups. It should be noted that 100% functionalization would mean
that 50% of all present azide groups had reacted. The reference of 50% is selected
because it is assumed that 50% of the azide groups would be on the surface of the interior
cavity of the polymersome and unavailable to react with the glycopolymer. A previous
study on the amount of azide groups available to react on the surface of PBD-PEG
polymersomes indicated that the above assumption is reasonable.39,42
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Table 2.2. Table summarizing the percentage of functionalized azide groups relative to
the total number of available azide groups.
10% of PBD-PEG-N3 (%)

100% of PBD-PEG-N3 (%)

PAGal9-Rho

82

74

PAGal19-Rho

90

70

PSGal8-Rho

89

2.4 Difficulties in the reproducibility of polymersome
preparation

At this stage in the project, difficulties arose with the reproducibility of the selfassembled polymersomes. The irreproducible nature of the polymersome formation may
be attributed to the potential crosslinking of free double bonds in the PBD block of the
PBD-PEG block copolymers. The recent 1H NMR spectrum of the PBD-PEG block
copolymer appeared similar to the spectrum recorded a year earlier. A large decrease in
the integration of the vinyl peaks at around 5.4 ppm would have been a clear indication of
crosslinking. However small decreases, or a small amount of crosslinking, couldn’t be
accurately assessed due to the broad nature of polymer 1H NMR peaks. Minor changes in
the chemical properties of the polymer sample, even by small amounts of crosslinking or
oxidation, could disrupt the self-assembly of polymersomes. It should be noted that
small, unidentifiable changes to the self-assembly technique, could also be responsible
for the change in observed morphology. Polymer Source, the polymer provider,
discontinued the exact polymer sample the Gillies group had previously used, so a fresh
batch of polymer could not be ordered. Ultimately, due to the issues with reproducibility
and availability, a more robust system for forming polymersomes using a polymer we
could make in the lab was selected for future studies.
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2.5 Azide Functionalized PEG-PEtG-PEG Polymersomes

Poly(ethyl glyoxylate) (PEtG) is a hydrophobic polymer that has been shown to selfassemble when coupled with PEG. The Gillies group has previously shown that MeOPEG-PEtG-PEG-OMe triblock polymers self-assembled into vesicle morphologies
when the length of each terminal PEG was 750 g/mol and the PEtG block was ~63,000
g/mol.45 In order to produce functionalizable polymersomes of PEtG and PEG, azides
were incorporated onto the triblock termini (N3-PEG-PEtGUV-PEG-N3). To vary the
degree of surface functionalization, a similar triblock copolymer with methyl ether
terminal groups was also prepared (MeO-PEG-PEtGUV-PEG-OMe) (Figure 2.7).
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Figure 2.7. Structures of the target triblock copolymers (a) MeO-PEG-PEtGUV-PEGOMe (550) and (b) N3-PEG-PEtGUV-PEG-N3 (600) and N3-PEG-PEtGUV-PEG-N3
(1000).
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The first step in the synthesis of the triblocks was making the PEG portions. Compound 8
(Mn = 550 g/mol) and 11 (Mn = 600 g/mol) and 12 (Mn = 1,000 g/mol), were reacted with
mesyl chloride, 9, to convert the alcohol into a good leaving group (Scheme 2.7). The
mesylated PEGs, 10, 13, and 14, were then reacted with sodium azide to afford the
corresponding azide-terminated PEGs MeO-PEG-N3 (550), N3-PEG-N3 (600), and N3PEG-N3 (1000). 1H NMR spectroscopy indicated the successful substitution of the mesyl
group with an azide group in all cases. The substitution was indicated by the
disappearance of the methyl peak of the mesyl group at 3.1 ppm. In addition, IR
spectroscopy confirmed the presence of an azide peak in MeO-PEG-N3 (550), N3-PEGN3 (600), and N3-PEG-N3 (1000) at ~2098 cm-1. Two PEG di-azide compounds of
different lengths were made to test the effect of PEG length on self-assembly. Previous
examples of MeO-PEG-PEtG-PEG-OMe that could form polymersomes used PEG
with an Mn of 750 g/mol, but a diol form with a similar Mn was not commercially
available.
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Scheme 2.7. Synthesis of (a) mono-azide terminated PEG, MeO-PEG-N3, and (b) diazide terminated PEG, N3-PEG-N3.

36

The PEtG portion of the triblock, PEtGUV (Scheme 2.8) with alkyne terminal groups was
previously prepared and had an Mn of 72,000 and Đ of 1.9. It is important to note that the
end-cap used is reactive with UV light, and this could be taken advantage of to trigger
polymer degradation. However, it was not the goal of the current work to take advantage
of the degradable properties. CuAAC was used to couple the PEGs to the PEtGUV
(Scheme 2.8). For the reaction between PEtG and both N3-PEG-N3 compounds, a molar
excess of up to 100 times was used. It would have required a multi-step synthesis to form
a unilaterally functionalized PEG moiety. Instead, by using a large excess of N3-PEG-N3,
a statistical mixture favouring the exclusive reaction of N3-PEG-N3 and PEtGUV alkyne
was used. This approach minimized the reaction of a single N3-PEG-N3 with two
different alkyne terminated PEtGUV polymers, which prevented the potential formation
of a copolymer containing five or more blocks. The resulting triblock polymers were
characterized using 1H NMR spectroscopy, Fourier-transform infrared spectroscopy (FTIR), and SEC. 1H NMR spectroscopy indicated that the coupling of all three PEG
compounds to PEtGUV was successful, based on the appearance of the expected PEG
peaks at around 3.64 ppm (Figure 2.8). FT-IR did not show any sharp peaks at ~2098 cm1

, which are expected if there is unreacted PEG azide in the sample (Figure 2.9).

However, the lack of an azide related peak could have been due to the relatively small
amount of azide compared to the amount of polymer, thus, SEC was used to confirm that
only trace amounts of PEG were present and the respective peaks in the 1H NMR
spectrum are not from excess unreacted PEG (Figure 2.10). It was concluded that the
CuAAC reaction and subsequent purification was successful.
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Figure 2.8. 1H NMR spectrum (400 MHz, CDCl3) of MeO-PEG-PEtGUV-PEG-MeO

Transmittance (%)

(550).

Wavenumber (cm-1)

Figure 2.9. FT-IR spectrum of MeO-PEG-PEtGUV-PEG-MeO (550).
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Figure 2.10. Overlay of the SEC traces for (a) MeO-PEG-PEtGUV-PEG-MeO (550)
and (b) MeO-PEG-N3.
Various ratios of polymers MeO-PEG-PEtGUV-PEG-MeO (550) and N3-PEG-PEtGUVPEG-N3 (600) were self-assembled to alter the surface azide density. In order to visualize
the resulting assemblies, they were loaded with perylene, a hydrophobic fluorescent
probe that excites at 410 nm. This probe was selected because the excitation and emission
curves do not overlap with the respective curves of the rhodamine labelled
glycopolymers, PSGal-Rho, allowing for direct quantification by fluorescence
microscopy after imaging with CLSM. Unfortunately, the self-assembly of MeO-PEGPEtGUV-PEG-MeO (550), N3-PEG-PEtGUV-PEG-N3 (600), or PEG-PEtGUV-PEG-N3
(1000) at any ratio (10%, 20%, or 50%) initially lead to small particles could be imaged
by CLSM, but no distinguishable membrane structure typical of vesicle morphology was
observed (Figure 2.11). Transmission electron microscopy (TEM) is commonly used to
visualize the morphology of smaller particles, but unfortunately the instrument was
unavailable for an extended period of time, which prevented analysis by TEM. The self-
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assembly of samples containing exclusively polymer MeO-PEG-PEtGUV-PEG-MeO
(550), N3-PEG-PEtGUV-PEG-N3 (600), or PEG-PEtGUV-PEG-N3 (1000) were tested to
determine if large polymersomes could be formed by a single triblock, rather than a
mixture. The results indicated that small particles formed for all three triblock samples.
The z-average diameter of the assemblies MeO-PEG-PEtGUV-PEG-MeO (550) and N3PEG-PEtGUV-PEG-N3 (600) were determined to be 182 nm with a PDI of 0.06 and
155.9 with a PDI of 0.143 by DLS. The PDI for a sample to be considered monodisperse
must be less than 0.2. Thus, the assemblies of MeO-PEG-PEtGUV-PEG-MeO (550) and
N3-PEG-PEtGUV-PEG-N3 (600) are both monodisperse and could be useful for
functionalization depending on the morphology determined by TEM imaging in the
future.

10 µm

Figure 2.11. CLSM images of the PEG-PEtGUV-PEG-N3 (1000) suspension, showing
that small particles were obtained.
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A MeO-PEG-PEtGThermo-PEG-OMe triblock polymer containing a PEtGThermo block
with an Mn of 63,000 g/mol and PEG with an Mn of 750 g/mol, and a thermos-responsive
end-cap (Figure 2.12) was shown by the Gillies group to form large polymersomes that
could be visualized by CLSM. To take advantage of this polymersome forming triblock
polymer and form large easily visualized polymersomes coated with azide groups, MeOPEG-PEtGThermo-PEG-OMe was mixed with PEG-PEtGUV-PEG-N3 (1000). The ratios
selected were 10%, 30%, and 50% PEG-PEtGUV-PEG-N3 (1000) to MeO-PEGPEtGThermo-PEG-OMe. Preliminary CLSM images of the mixed suspensions indicated
larger vesicle and smaller particles morphologies were present (Figure 2.13). Similar
mixed morphologies were observed for all polymer ratios. By optimizing both the mixing
ratios and methods used to form the assemblies, mixing MeO-PEG-PEtGThermo-PEGOMe and PEG-PEtGUV-PEG-N3 (1000) may present a viable route to achieving
reproducible and functionalizable polymersomes.
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a)

b)

10 µm

10 µm

Figure 2.13. (a) Large vesicle morphology and (b) small particles observed within the
same 10 wt% N3-PEG-PEtGUV-PEG-N3 (1000) 90 wt% MeO-PEG-PEtGThermo-PEGOMe (750) nanoparticle suspension.
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Chapter 3

3

Experimental

General Procedures and Methods. Compounds 146, 2, 5 ,744, 447, 1048, 1348 and 1448
were prepared as previously reported. PEtGUV had an Mn = 54,000 g/mol and Đ = 2.2 by
SEC in THF. PEtGThermo had an Mn = 63,000 g/mol and Đ = 2.0 by SEC in THF. DIPEA
and dichloromethane were distilled from calcium hydride before use. Anhydrous THF
was obtained from a solvent purification system using aluminum oxide columns. All
other solvents were purchased from Caledon Labs. All the other chemicals were reagent
grade and used without further purification. NMR spectra were obtained on 400 or 600
MHz Varian Inova spectrometers (Agilent Tech., Santa Clara, CA). NMR chemical shifts
(δ) are reported in ppm and are calibrated against the residual solvent signals of CDCl3 (δ
7.27; 77.4), CD3CN (δ 1.94; 116.4), d6-DMSO (δ 2.50; 40.8), or D2O (δ 4.75). Size
exclusion chromatography (SEC) was performed using a Viscotek GPC Max VE2001
solvent module (Agilent Tech.), a Viscotek VE3580 RI detector operating at 30 °C, two
Agilent Polypore (300 × 7.5 mm) columns connected, and a Polypore guard column (50
× 7.5 mm). THF (glass distilled grade) was used as the eluent. A calibration curve was
obtained from polystyrene standards. Dialysis was performed using Spectra/Por 6
regenerated cellulose membranes from Spectrum Laboratories (Rancho Dominguez, CA,
USA). Fourier-transform infrared (FT-IR) spectra were obtained in attenuated total
reflectance (ATR) mode using a PerkinElmer UATR Spectrum Two, with bulk material
deposited on the diamond. Ultrapure water was obtained from a Barnstead EASYpure II
system. The Z-average diameters of the polymersome assemblies were measured by
dynamic light scattering (DLS) using a Zetasizer Nano Series ZS instrument from
Malvern Instruments, at room temperature (25 ºC) in a 1 cm path length low volume (1
mL) polystyrene cuvette at a polymer concentration of 0.8 mg/mL. Fluorescence spectra
were obtained using a QM-SE spectrometer from Photon Technology International (PTI).
Thermogravimetric analyses (TGA) were performed on a TGA Q50 from TA
Instruments. The heating rate was 10。C /min between 15-1000 ºC under N2

(g).
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Differential scanning calorimetry (DSC) was performed using a Q2000 from TA
Instruments. The heating/cooling rate was 10 ºC/min from -70 to +150 ºC. Glass
transition temperatures (Tg) were obtained from the third heating cycle.
Synthesis of SAcGal. 1-O-2-Azidoethyl-β-D-galactose tetraacetate46 (19 g, 46 mmol, 1.0
equiv.) was dissolved in minimal dimethylformamide (DMF) with stirring. Sequentially,
CuSO4 (0.90 g, 4.6 mmol, 0.10 equiv.), (+)-Sodium L-ascorbate (2.7 g, 4.6 mmol, 0.10
equiv.), and compound 4 (9.4 g, 55 mmol, 1.2 equiv.) dissolved in minimal DMF, were
added to the flask. 450 mL of 4:1 DMF:water was added to the mixture and it was heated
with rapid stirring at 50 °C overnight. The reaction mixture was concentrated in vacuo
and the crude product dissolved in CH2Cl2 (500 mL), washed with water, brine (300 mL
each). The organic layer was dried with MgSO4, filtered and concentrated. The crude
mixture was precipitated twice from minimal THF into cold pentane and residual solvent
removed under high vacuum to yield SAcGal (14.5 g, 55%). 1 g of BHT in 20 mL of
dichloromethane was added to the SAcGal and the solution was stored in a -20 ºC freezer
to prevent polymerization. 1H NMR (400 MHz, CD3CN): δppm 7.52 (s, 1H), 7.24 (d, 2H, J
= 8.0 Hz), 7.13 (d, 2H, J = 8.0 Hz), 6.56 (dd, 1H, J = 12.0, 16.0 Hz), 5.60 (d, 1H, J = 16.0
Hz), 5.12 (d, 1H, J = 4 Hz), 5.05 (d, 1H, J = 12.0 Hz), 4.83-4.75 (m, 2H), 4.40-4.30 (m,
8H), 3.99-3.91 (m, 2H), 1.70 (s, 6H), 1.87 (s, 3H), 1.79 (s, 3H), 1.71 (s, 6H). FT-IR (cm1

, film from CH2Cl2): 2867, 1743, 1368, 1218, and 1046 cm-1.

Synthesis of PSAcGal8 and the general procedure for the polymerization of SAcGal.
Before use, SAcGal containing BHT was dissolved in CH2Cl2 and loaded onto a silica
plug. BHT was eluted with CH2Cl2 and discarded. The monomer was then eluted with
100% methanol. The methanol was removed in vacuo and the purified SAcGal (1.2 g, 2.2
mmol, 13 equiv.), CTA (compound 5) (50 mg, 170 µmol, 1.0 equiv.), and AIBN, 6, (9.4
mg, 57 µmol, 0.33 equiv.) were deposited in a reaction tube and dissolved in acetonitrile
(1 mL). The polymerization mixture was subjected to four cycles of freeze-pump-thaw. A
freeze-pump-thaw cycle began with freezing the polymerization mixture using liquid
nitrogen under a positive pressure of N2

(g).

Once the sample was frozen, the flask was

placed under active high vacuum for 5 min, with the flask remaining in liquid nitrogen.
The flask was removed from the liquid nitrogen and placed under static vacuum, until the
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sample was thawed. The sample would then be re-frozen, and the cycle repeated the
desired number of times. After being placed under positive pressure of N2 (g), the mixture
was heated to 75 °C and stirred rapidly for 36 h. The polymerization mixture was allowed
to cool to room temperature and concentrated. The crude polymer was dissolved in DMF
(2 mL) and dialyzed against 1 L of DMF using a 2,000 g/mol MWCO membrane for 18
h. The solution was concentrated yielding PSAcGal8 (910 mg, 76%). 1H NMR (400
MHz, CDCl3): δppm 7.65 (br s, 1H), 7.23-6.30 (br, 4H), 5.38 (br s, 1H), 5.19 (br, 1H), 5.00
(br s, 1H), 4.76-4.35(br, 7H), 4.26 (s, 1H), 4.26 (m, 2H), 3.94 (br s, 2H), 2.15-1.96 (m,
13H), 1.72-1.30 (br, 4H), 0.89 (br s, 1H). SEC: Mn = 4,700 g/mol, Mw = 5,300 g/mol, Đ
= 1.1.
Synthesis of PSAcGal18. The polymer was synthesized by the same procedure described
for PSAcGal8 except for the following changes. Purified SAcGal (1.2 g, 2.2 mmol, 45
equiv.), CTA (compound 5) (14 mg, 48 µmol, 1.0 equiv.), and AIBN (2.6 mg, 16 µmol,
0.33 equiv.) were deposited in a reaction tube and dissolved in acetonitrile (1 mL). The
polymerization mixture was heated at 75 ºC with rapid stirring for 6 days. Purification
yielded PSAcGal18 (690 mg, 57%). 1H NMR (400 MHz, CDCl3): δppm 7.65 (br s, 1H),
7.15-6.15 (br, 4H), 5.37 (br s, 1H), 5.15(br, 1H), 4.98 (br s, 1H), 4.67-4.28(br, 7H), 4.23
(s, 1H), 4.12 (m, 2H), 3.92 (br s, 2H), 2.18-1.77 (m, 13H), 1.75-1.09 (br, 4H), 1.25 (m,
4H), 0.83 (br s, 1H). SEC: Mn = 10,000 g/mol, Mw = 11,000 g/mol, Đ = 1.1.
Synthesis of PSGal8 and the general procedure for the deprotection of PSAcGal.
PSAcGal8 (350 mg, 75 µmol, 1.0 equiv.) was deposited in a flame dried round bottom
flask and dissolved in 10 mL of anhydrous methanol. The reaction flask was placed in a 0
ºC ice bath and sodium methoxide (200 mg, 3.7 mmol, 50 equiv.) solid was added to the
flask slowly. The flask was removed from the ice bath after 30 min and allowed to warm
to room temperature. The reaction mixture was stirred for 16 h and checked by thin layer
chromatography (TLC) (100% Methanol) to confirm complete deprotection. The pH of
the resulting solution was adjusted to 7 using NH4Cl and concentrated. The resulting
crude compound was dissolved in 2 mL of DI water and purified by dialysis against DI
water using a 2,000 MWCO membrane. The water was removed using a freeze dryer
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affording PSGal8 (190 mg, 72%). 1H NMR (400 MHz, D2O): δppm 7.91-7.32 (br), 7.105.83 (br), 4.25-2.91 (br), 2.89-2.62 (br), 1.55-1.37 (br), 1.24-1.05 (br), 0.84-0.20 (br).
Synthesis of PSGal18. The polymer was deprotected by the same procedure described for
PAcGal8 except for the following amounts were used. PSAcGal18 (500 mg, 50 µmol, 1.0
equiv.) and sodium methoxide (200 mg, 3.7 mmol, 74 equiv.). Purification yielded
PSGal18 (230 mg, 63%). 1H NMR (600 MHz, D2O): δppm 8.27-7.74 (br), 7.43-6.02 (br),
4.75-3.14 (br), 2.05-0.45 (br).
Synthesis of PSGal8-Rho and the general procedure for the Rhodamine labelling
PSGal. PSGal8 (150 mg, 48 µmol, 1.0 equiv.) was dissolved in minimal DMF. EDC.HCl
(16 mg, 100 µmol 2.1 equiv.), DPTS (3.6 mg, 17 µmol, 0.35 equiv.), and DMAP (2 mg,
20 µmol, 0.4 equiv.) were added to the stirring solution simultaneously. Rhodamine B
(3.2 mg, 6.7 µmol, 0.14 equiv.) was then added to the solution slowly. The solution was
stirred overnight. The crude reaction mixture was dialyzed against 1L of DI water using
2,000 MWCO dialysis tubing for 48 h, with the dialysate being changed twice. The
polymer solution was concentrated yielding PSGal8-Rho. The polymer was used as-is
and was not fully characterized. lmax Absorbance = 510 nm. lmax Emission = 584 nm.
Extinction Coefficient = 618,000 mL/mg at 584 nm.
Synthesis of PSGal18-Rho. The polymer was labelled by the same procedure described
for PAcGal8-Rho except for the following amounts were used. PSGal18 (100 mg, 10
µmol, 1.0 equiv.), EDC.HCl (3.6 mg, 23 µmol, 2.3 equiv.), DPTS (0.82 mg, 3.8 µmol,
0.38 equiv.), DMAP (0.5 mg, 4 µmol, 0.40 equiv.), and Rhodamine B (3.2 mg, 1.5 µmol,
0.15 equiv.) The polymer solution was concentrated yielding PSGal18-Rhodamine. The
polymer was used as-is and was not fully characterized. lmax Absorbance = 510 nm. lmax
Emission = 574 nm. Extinction Coefficient = 813,000 mL/mg at 574 nm.
Synthesis of MeO-PEG-N3 (550) and the general procedure for the synthesis of
PEG-N3 compounds. Compound 1048 (20 g, 33 mmol, 1.0 equiv.) was dissolved in
DMF. Sodium azide (21 g, 320 mmol, 9.7 equiv.) was added with stirring. An air
condenser was added to the flask, which was then heated to 80 ºC and stirred overnight.
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The DMF was removed in vacuo and the crude product was dissolved in 500 mL of
dichloromethane, filtered, and then washed with DI water (30 mL x2). The organic phase
was concentrated, then water was removed using a toluene wash (3 x 200 mL). The
product was dissolved in minimal dichloromethane and precipitated into cold diethyl
ether. The ether was decanted, the precipitate collected, and dried on high vacuum to
yield MeO-PEG-N3 (550) (14 g, 75%). 1H NMR (400 MHz, CDCl3): δppm 3.68-3.62 (m,
49H), 3.56-3.52 (m, 2H), 3.40-3.35 (m, 5H). FT-IR: 2865, 2103, 1456, 1348, 1293, 1249,
1100 cm-1. SEC: Mn = 380 g/mol, Mw = 490 g/mol, Đ = 1.3.
Synthesis of N3-PEG-N3 (600). The azide was substituted by the same procedure
described for MeO-PEG-N3 (550) except for the following amounts were used.
Compound 1348 (18 g, 25 mmol, 1.0 equiv.) and sodium azide (18 g, 280 mmol, 11
equiv.). Purification yielded N3-PEG-N3 (600) (14 g, 75%). 1H NMR (400 MHz, CDCl3):
δppm 3.66-3.59 (m, 57H), 3.36 (t, J = 12 Hz, 4H). FT-IR: 2865, 2098, 1456, 1347, 1287,
1249, 1100 cm-1. SEC: Mn = 470 g/mol, Mw = 571 g/mol, Đ = 1.2.
Synthesis of N3-PEG-N3 (1000). The azide was substituted by the same procedure
described for MeO-PEG-N3 (550) except for the following amounts were used.
Compound 1448 (20 g, 20 mmol, 1.0 equiv.) and sodium azide (11 g, 170 mmol, 8.5
equiv.). Purification yielded N3-PEG-N3 (1000) (14 g, 75%). 1H NMR (600 MHz,
CDCl3): δppm 3.59-3.51 (m, 91H), 3.29 (t, J = 6 Hz, 4H). FT-IR: 2865, 2098, 1456, 1347,
1287, 1249, 1100 cm-1. SEC: Mn = 1,400 g/mol, Mw = 1,500 g/mol, Đ = 1.1.
Synthesis of MeO-PEG-PEtGUV-PEG-OMe and the general procedure for the
coupling of PEG to PEtG. MeO-PEG-N3 (550) (30 mg, 52 µmol, 19 equiv.) was
dissolved in 2 mL of DMF. 10 mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and
PEtGUV (150 mg, 2.8 µmol, 1.0 equiv.) were subsequently added to the solution. The
solution was heated with stirring for 18 h at 40 ºC. The resulting solution was dialyzed
against 1L DI water, using a 3,500 g/mol MWCO membrane, overnight. The water was
removed using a freeze dryer to yield MeO-PEG-PEtG-PEG-OMe (120 mg, 78%). 1H
NMR (400 MHz, CDCl3): δppm 5.70-5.52 (m, 833H), 4.21 (br s, 1705), 3.67-3.52 (br,
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100H), 1.30-1.27 (m, 2591H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1.
SEC: Mn = 65,000 g/mol, Mw = 271,000 g/mol, Đ = 4.2.
Synthesis of N3-PEG-PEtGUV-PEG-N3 (600). N3-PEG-N3 (600) was coupled to
PEtGUV by the same procedure described for MeO-PEG-PEtGUV-PEG-OMe except for
the following amounts were used. N3-PEG-N3 (600) (120 mg, 190 µmol, 68 equiv.), 10
mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and PEtGUV (150 mg, 2.8 µmol, 1.0
equiv.). Purification yielded N3-PEG-PEtGUV-PEG-N3 (600) (120 mg, 78%). 1H NMR
(600 MHz, CDCl3): δppm 5.73-5.46 (m, 868H), 4.22 (br s, 1757), 3.67-3.54 (br, 109H),
1.30-1.27 (m, 2788H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1. SEC:
Mn = 60,000 g/mol, Mw = 162,000 g/mol, Đ = 2.7.
Synthesis of N3-PEG-PEtGUV-PEG-N3 (1000). N3-PEG-N3 (1000) was coupled to
PEtGUV by the same procedure described for MeO-PEG-PEtGUV-PEG-OMe except for
the following amounts were used. N3-PEG-N3 (1000) (300 mg, 270 µmol, 96 equiv.), 10
mg of CuSO4, 10 mg of (+)-sodium L-ascorbate, and PEtGUV (150 mg, 2.8 µmol, 1.0
equiv.). Purification yielded N3-PEG-PEtGUV-PEG-N3 (1000) (120 mg, 78%). 1H NMR
(600 MHz, CDCl3): δppm 5.71-5.46 (m, 965H), 4.22 (br s, 1952H), 3.66-3.56 (br, 184H),
1.30-1.27 (m, 3028H). FT-IR: 2984, 2917, 2850, 1750, 1215, 1013, and 957cm-1. SEC:
Mn = 108,000 g/mol, Mw = 492,000 g/mol, Đ = 4.6.
PBD-PEG Nanoparticle Preparation. The procedure was adapted from a previously
reported method.42 In a 3-mL dram vial, 5.0 mg of polymer (PBD-PEG-OH, PBD-PEGN3, or a mixture) was mixed with 50 µg of the hydrophobic dye Nile Red in 0.5 mL of
chloroform and then the solvent was evaporated under a stream of nitrogen gas. The
resulting thin film was further dried under high vacuum overnight to remove traces of
solvent. The thin film was then hydrated overnight with 0.5 mL of filtered Ultrapure
water and kept at 46 °C. A stir bar was then added to the vial and it was rapidly stirred
(1000 rpm or greater) overnight. The vesicles were then imaged by confocal laser
scanning microscopy (see below).
PEG-PEtG-PEG Nanoparticle Preparation. 8 µL of 0.1 mg/mL perylene in
dichloromethane solution was added to a dram vial and the solvent was evaporated using

49

a stream of nitrogen gas. 100 µL of 8 mg/mL triblock in THF (MeO-PEG-PEtG-PEGOMe or N3-PEG-PEtG-PEG-N3, or a mixture of both) triblock in THF was added to the
vial along with a small magnetic stir bar. The solution was stirred for 5 min, then at a stir
rate of 400 rpm, 0.9 mL of DI water was added dropwise (~1 drop per second). After
stirring for another 20 min, the suspension was transferred to a 50,000 MWCO dialysis
membrane and dialyzed against 1L of DI water to remove the THF. The resulting
suspension was stored in a 4 ºC fridge.
Confocal Laser Scanning Microscopy (CLSM). 10 µL of the aqueous suspension of
polymersomes was dropped onto a glass slide, a glass coverslip was placed on top, and
the outside edges of the coverslip were sealed with nail polish. The slides were stored at 4
ºC for 2 h prior to imaging. Images were obtained using a confocal laser scanning
microscope (LSM 510, Carl Zeiss Inc.) using a 63X (Nanoparticles suspensions which
contained Nile Red) and 100X (Nanoparticles suspensions which contained PAGalRhodamine, PSGal-Rhodamine, or perylene) oil immersion objective, and an excitation
wavelength of 543 nm (Nanoparticles suspensions which contained Nile Red, PAGalRhodamine, or PSGal-Rhodamine) and 405 nm (Nanoparticles suspensions which
contained perylene).
Fluorescence Calibration Curves. PAGal-Rhodamine and PSGal-Rhodamine were
dissolved in dimethyl sulfoxide (DMSO) to achieve a concentration of 0.25 mg/mL. The
solution was then diluted with DMSO to obtain measurements at a minimum of four
different concentrations ranging from 0.05 mg/mL to 0.25 mg/mL. Acquisition settings
were as follows: Excitation @ 562 nm, Emission from 565 to 610 nm, Length = 45 nm,
Step Size = 0.25 nm, Integration = 1 s, Averages = 1. The 3 mL glass cuvette was rinsed
3 times with 1.5 mL of DMSO between samples. All measurements were taken in
triplicate and then averaged to obtain the values used for the calibration curve.
Fluorescence Spectroscopy to Quantify Azide-Alkyne Click. Each nanoparticle
suspension had the water removed using a freeze dryer to yield a powdered sample. The
sample was then dissolved in 1 mL of DMSO. The fluorescence counts were then
measured using the same parameters used to create the calibration curves. All

50

measurements were taken in triplicate and then averaged to obtain the concentration
values.
Method to Calculate the Percentage of Functionalized Azide Groups. To calculate the
percentage of functionalized N3 groups, first the theoretical yield of the click reaction was
determined. The mass of the PBD-PEG was adjusted for the relative amount of azide
density, where polymer samples containing 10% PBD-PEG-N3 were multiplied by 0.1
and 100% azide functionalized PBD-PEG-N3 were multiplied by 1. The mass was then
adjusted for the amount of available azide due to the nature of vesicles. PBD-PEG-N3
will be on the inside of the polymersome, with the expected ratio being 50:50 inside:
outside. To make the appropriate adjustment, the mass was multiplied by 0.5. The moles
of azide were calculated by dividing the mass of available azide by the molar mass of the
PBD-PEG-N3 which was approximately 10000 g/mol. The moles of azide were assumed
to be equal to the moles of alkyne functionalized glycopolymer as they react in a 1:1
ratio. Multipling the moles of alkyne functionalized glycopolymer by the molar mass of
the respective polymer, short glycopolymer = 2,400 g/mol or long glycopolymer = 5,200
g/mol, the expected or theoretical mass of dyed glycopolymer was determined. The
experimental yield or mass of dyed glycopolymer, determined using the calibration
curve, was divided by the theoretical yield to determine the percent functionalization of
the azide groups on the vesicles.
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Chapter 4

4

Conclusions and Future Work

The work in this thesis provided progress towards producing glycopolymer
functionalized polymersomes and quantifying their degree of functionalization. It was
shown that the degree of PBD-PEG polymersome surface functionalization could be
quantified by measuring the fluorescence of a glycopolymer, PAGal, labelled with
rhodamine B. Difficulty with the synthesis of the PAAcGal led to the development and
synthesis of a second glycopolymer with pendent b-D-galactose moieties, PSAcGal.
PSAcGal having two different DPn values were synthesized, deprotected, and labelled
with rhodamine B.
The shorter dye-labelled glycopolymer was conjugated to the surface of PBD-PEG
polymersomes, yielding similar surface functionalization as the previous glycopolymer,
PAGal. The relative amount of functionalization that could be achieved when the
polymersomes had 10% compared to 100% of the surface containing an azide group, was
determined for each length of dye-labelled glycopolymer. The results indicated that the
length of the glycopolymer did not significantly affect the yield of the CuAAC reaction,
but that a higher yield was obtained at lower azide densities. It is speculated that the high
degree of steric hindrance associated with functionalizing every azide group on the
surface of the polymersome decreased CuAAC reaction yields for 100% azide coated
polymersomes.
Although initial conjugation experiments were performed, there were subsequently issues
with the reproducibility of the PBD-PEG polymersomes. The issues of reproducibility
lead to the proposal of an alternative block copolymer platform. A triblock polymer,
MeO-PEG-PEtGUV-PEG-OMe, previously shown to reproducibly form polymersomes,
that could be functionalized with azide groups. A new MeO-PEG-PEtGUV-PEG-OMe
(550) triblock and two azide functionalized triblock polymers, N3-PEG-PEtGUV-PEGN3 (600) and PEG-PEtGUV-PEG-N3 (1000), were produced and characterized. The self-
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assembly of MeO-PEG-PEtGUV-PEG-OMe and N3-PEG-PEtGUV-PEG-N3 triblock
polymers individually and in mixtures led to the formation of nanoparticles that were too
small to be imaged by CLSM. However, the mixture of a thermo-responsive analog
triblock, MeO-PEG-PEtGThermo-PEG-OMe, and N3-PEG-PEtGUV-PEG-N3 yielded
suspensions containing large polymersomes that could be imaged with CLSM along with
smaller particles. CLSM could not be used to determine if the smaller particles were
polymersomes or not.
In terms of future work, the self-assembly protocol of MeO-PEG-PEtGThermo-PEGOMe and N3-PEG-PEtGUV-PEG-N3 mixtures must be optimized to achieve
monodisperse samples of large polymersomes. These large polymersomes could then be
functionalized
functionalization

with

dye-labelled

densities.

The

glycopolymers
binding

of

the

to

determine

glycopolymer

the

relative

functionalized

polymersomes could then be determined with lectin binding assays. Alternatively, if the
small nanoparticles produced by N3-PEG-PEtGUV-PEG-N3 can be imaged with TEM
and a vesicle morphology is observed, then they would be another candidate for further
functionalization with glycopolymers. The next steps towards optimizing a PEtG
containing triblock that can be self-assembled into polymersomes and functionalized with
glycopolymers involves synthesizing triblock polymers with lower dispersities. Triblock
polymers with lower dispersities would likely increase the reproducibility of
polymersome formation by making the hydrophilic weight fraction more consistent
within a polymer sample. Since hydrophilic weight fraction affects the morphology
achieved with self-assembly, lower dispersities should make the self-assembly results
more consistent. Reproducibly producing functionalizable polymersomes would create
opportunities to take advantage of the tuneable degradation of the PEtG block. A system
can be imagined where glycopolymers on the outside of a polymersome allow for
specific targeting of a pathogen. After binding the pathogen, an enzyme, change in pH, or
the presence of reducing agents at the surface of the pathogen could cause the
degradation of the polymersome, releasing an anti-viral or anti-bacterial drug.
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Appendices

Figure A.0.1. 1H NMR Spectrum of PAGal19-Rho. (DMSO-d6, 400 MHz)
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Figure A.0.2. 1H NMR Spectrum of crude AAcGal. (CDCl3, 600 MHz)

Figure A.0.3. 1H NMR Spectrum of PSAcGal18. (CDCl3, 600 MHz)
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Figure A.0.4. 1H NMR Spectrum of PSGal8-Rho. (D2O, 600 MHz)

Figure A.0.5. 1H NMR spectrum of PBD-PEG-OH. (CDCl3, 400 MHz)
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Figure A.0.6. 1H NMR spectrum of PBD-PEG-N3. (CDCl3, 600 MHz)

Figure A.0.7. 1H NMR spectrum of N3-PEG-PEtGUV-PEG-N3 (600).(CDCl3, 600 MHz)
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Figure A.0.8. 1H NMR spectrum of N3-PEG-PEtGUV-PEG-N3 (1000). (CDCl3, 600
MHz)

Figure A.0.9. FT-IR spectrum of SAcGal.
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Figure A.0.10. FT-IR spectrum of N3-PEG-PEtG-PEG-N3 (1000).
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Figure A.0.11. SEC overlay of N3-PEG-PEtG-PEG-N3 (600) and N3-PEG-N3 (600).
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Figure A.0.12. TGA trace of PSAcGal8.

Figure A.0.13. DSC trace for PSAcGal8.
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Figure A.0.14. Fluorescence Calibration Curve for PSGal8-Rho.
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Figure A.0.15. Fluorescence Calibration Curve for PSGal18-Rho.
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Figure A.0.16. Rights and Permission to reprint Figure 1.4.

68

Curriculum Vitae
Josh Jadischke
Education
M.Sc. Synthetic Organic Chemistry
University of Western Ontario, London, ON, Canada

May 2016 –
April 2018

Thesis: Glycopolymer Functionalization of
Polymersomes
B.Sc. Chemistry

April 2016

University of Western Ontario, London, ON, Canada
Thesis: Self-healing Phosphonium Polymer Networks
Awards
Highly Commended Entrant
§

Nov. 2016

Award included invitation to present at a
conference in Ireland, along with recognition by
‘The Undergraduate Awards’.

Summer Company Grant
§

Summer 2015

A grant and training program offered by the
Ontario government to support new and high
growth potential small businesses.

Scholarship of Excellence
§

Sept. 2012

Entrance scholarship based on application
average – granted by the University of Western
Ontario.
Teaching Experience

TA, Organic Chemistry III, Chemistry

Fall 2017

Department, 70 h
TA, Organic Chemistry for Life Sciences,

Fall 2017

69

Chemistry Department, 140 h
TA, Organic Chemistry of Biological Sciences,

Winter 2017

Chemistry Department, 140 h
TA, Organic Chemistry for Life Sciences,

Fall 2016

Chemistry Department, 70 h
TA, Organic Chemistry I, Chemistry

Fall 2016

Department, 70 h
Publications
Cuthbert, T. J.; Jadischke, J. J.; De Bruyn, J. R.; Ragogna, P. J.; Gillies, E. R.
Self-Healing Polyphosphonium Ionic Networks. Macromolecules 2017, 50,
5253–5260.
Presentations
3. Jadischke, J. J., Raycraft, B.R., Whitton, G., Trant, J.F., and Gillies, E.R.
Glycopolymer Functionalization of Nanocarriers for Improved Microbial
Binding. Poster presentation delivered at Nano Ontario 2017, Toronto, ON,
Nov. 2017.
2. Jadischke, J. J., Raycraft, B.R., Whitton, G., Trant, J.F., and Gillies, E.R.
Glycopolymer Functionalization of Nanocarriers for Improved Microbial
Binding. Poster presentation delivered at Canadian Society for Chemistry
Conference and Exhibition, Toronto, ON, May 2017.
1. Jadischke, J. J., Raycraft, B.R., Whitton, G., Trant, J.F., and Gillies, E.R.
Glycopolymer-functionalized vesicles via aqueous RAFT polymerization from
vesicle surface. Poster presentation delivered at the Fallona Family
Interdisciplinary Research Showcase, London, ON, January 2017.

